Allianz Biotechnologie - A - EUR/ DE0008481862 /
| NAV26/07/2024 | Chg.+2.0100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 223.1900EUR | +0.91% | paying dividend | Equity | Allianz Gl.Investors ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 27/07/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 13/05/2024 | PRIIP Key Information Document | 2024 | English | 300.46 KB |
| 13/05/2024 | PRIIP Key Information Document | 2024 | German | 264.56 KB |
| 15/01/2024 | Prospectus | 2024 | German | 1,042.62 KB |
| 31/12/2023 | Account statment | 2023 | English | 178.80 KB |
| 31/12/2023 | Account statment | 2023 | German | 214.22 KB |
| 30/06/2023 | Semi-annual report | 2023 | English | 127.19 KB |
| 30/06/2023 | Semi-annual report | 2023 | German | 115.13 KB |
| 13/09/2022 | Key Investor Information | 2022 | English | 77.21 KB |
| 13/09/2022 | Key Investor Information | 2022 | German | 77.64 KB |
| 25/07/2022 | Prospectus | 2022 | English | 650.16 KB |
